Suven Life Sciences Limited
₹119.83
INR-0.16(-0.13%)
As of November 14, 2024 10:00:00 AMSuven Life Sciences Limited Share Price Information
24 hour Low and High
The lowest and highest prices reached in the last 24 hours of trading
Low: ₹119.41
High: ₹128
All time High
The highest price the stock has ever reached since being listed
₹164.66
Price Change 1h
Price change in the last hour of trading
+₹-6.23 +-4.94%
Price Change 1d
Price change over the last trading day
+₹-6.23 +-4.94%
Price Change 1w
Price change over the last week of trading
+₹-11.05 +-8.44%
Suven Life Sciences Limited Market Information
Exchange
The Exchange where the trading of the stock takes place
NSE
Market Cap
The current market capitalisation of the stock
2711.06 Cr
About Suven Life Sciences Limited Share
Suven Life Sciences Limited, a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders in India, the United States, Europe, and internationally. The company engages in drug discovery and development of new chemical entities in central nervous system diseases. Its product candidates include Masupirdine (SUVN-502) for the treatment of Alzheimer disease and neuropsychiatric symptoms; Samelisant (SUVN-G3031), a histamine 3 receptor inverse agonist for the treatment of sleep and cognitive disorders; and Ropanicant (SUVN-911), Alpha4Beta2 nAChRs receptor antagonist for the treatment of depressive disorders. The company is developing Usmarapride (SUVN-D4010), a potent, selective, and orally bio-available and brain penetrant 5-HT4 receptor partial agonist for the treatment of cognitive disorders; SUVN-I6107 for the treatment of cognitive disorders; SUVN-M8036 for the treatment of psychiatric disorders; and SUVN-D1044 for the treatment of gastrointestinal disorders. The company was formerly known as Suven Pharmaceuticals Pvt. Ltd. and changed its name to Suven Life Sciences Limited in 2003. The company was incorporated in 1989 and is headquartered in Hyderabad, India. Suven Life Sciences Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited.
Sector
Healthcare
Drug Manufacturers - Specialty & Generic
Employees
about
141
CEO
Mr. Venkateswarlu Jasti M.Pharm. M.S.
Revenue (2023)
%
Country of Origin
India
Key Highlights
- Suven Life hits life high after positive result for its depression drug
- Top Stock Recommendations: Osho Krishan of Angel One suggests buying Suven Life Sciences, and Sutlej Textiles today | Stock Market News
- Suven Life Sciences' Stock Continues to Decline, Underperforming Sector and Sensex
- Stocks in news: SpiceJet, Shriram Finance, Suven Pharma, Mazagon Dock, Suzlon Energy
- Cohance Lifesciences merger with Suven Pharma gets NSE, BSE nod
Suven Life Sciences Limited Resource
FAQs
The current price of Suven Life Sciences Limited is INR 119.83 — it has changed by -4.94% in the past 24 hours. Watch Suven Life Sciences Limited's stock price performance more closely on the chart.
Suven Life Sciences Limited has a market capitalization of 27110635520 as of today.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Suven Life Sciences Limited's EBITDA is INR undefined
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange Suven Life Sciences Limited stocks are traded under the ticker SUVEN
As of November 15, 2024, the company has 141 employees.